Atrial fibrillation trials recruiting in Missouri

All Atrial fibrillation trials nationally

Cities in Missouri

Recruiting trials in Missouri

• Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
  NCT04045665 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Missouri: Kansas City, St Louis
• Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
  NCT03907046 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Missouri: Columbia, Springfield, St Louis
• Baseline Atrial Fibrosis Predicts Risk for Post-operative Atrial Fibrillation in Patients Undergoing Cardiac Surgery
  NCT05014802 · Phase: Not specified · Ages: 40 Years to 120 Years · Sex: All (male and female) · Missouri: St Louis
• Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)
  NCT07298473 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Missouri: Kansas City
• Long Term Evaluation of Cardiac Arrhythmias After Transcatheter Aortic Valve Implantation -The LOCATE Registry
  NCT06055751 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Missouri: Kansas City
• Medtronic Terminate AF Study
  NCT03546374 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Missouri: St Louis
• Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
  NCT04088071 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Missouri: Columbia, Springfield
• Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
  NCT05712200 · Phase: Phase 3 · Ages: 65 Years and older · Sex: All (male and female) · Missouri: Kansa City, Kansas City, St Louis
• Surveillance Trial of the Apple Watch in Reliable Burden Assessment in Unseen Recurrence of Surgically Treated AF
  NCT07122947 · Phase: Not specified · Ages: 22 Years and older · Sex: All (male and female) · Missouri: St Louis
• The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
  NCT05836987 · Phase: Phase 3 · Ages: 22 Years to 85 Years · Sex: All (male and female) · Missouri: Kansas City, St Louis
• Tracking Results of Ablations to Combat AF Registry Generation 2
  NCT05111015 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Missouri: St Louis
• Vascular Closure With a Device Compared to Manual Compression After Atrial Fibrillation Ablation: The LockeT II Study
  NCT06078735 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Missouri: Independence, Kansas City